Erkan İbiş

533 total citations
34 papers, 374 citations indexed

About

Erkan İbiş is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Erkan İbiş has authored 34 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Erkan İbiş's work include Radiopharmaceutical Chemistry and Applications (6 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Medical Imaging and Pathology Studies (4 papers). Erkan İbiş is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Medical Imaging and Pathology Studies (4 papers). Erkan İbiş collaborates with scholars based in Türkiye and United States. Erkan İbiş's co-authors include Çiğdem Soydal, Ömer Küçük, Elgin Özkan, Gülseren Araş, Mine Araz, Metin Kır, Sadık Bilgiç, Sumru Beder, Oya Kayacan and Demet Karnak and has published in prestigious journals such as European Journal of Endocrinology, Seminars in Nuclear Medicine and Brain and Development.

In The Last Decade

Erkan İbiş

34 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erkan İbiş Türkiye 13 126 107 99 82 80 34 374
Chandra Sekhar Bal India 12 62 0.5× 136 1.3× 73 0.7× 59 0.7× 85 1.1× 23 330
Luca Burroni Italy 12 183 1.5× 71 0.7× 102 1.0× 203 2.5× 92 1.1× 40 516
Tanju Yusuf Erdıl Türkiye 8 62 0.5× 114 1.1× 89 0.9× 50 0.6× 52 0.7× 71 313
Ad Theeuwes Netherlands 14 218 1.7× 110 1.0× 33 0.3× 34 0.4× 53 0.7× 17 492
Pınar Özgen Kıratlı Türkiye 10 83 0.7× 102 1.0× 149 1.5× 52 0.6× 129 1.6× 34 378
Irina Lisinen Finland 11 118 0.9× 127 1.2× 211 2.1× 60 0.7× 36 0.5× 12 557
Hedieh K. Eslamy United States 9 111 0.9× 136 1.3× 85 0.9× 101 1.2× 54 0.7× 13 398
Marina Hodolič Italy 11 119 0.9× 223 2.1× 171 1.7× 25 0.3× 75 0.9× 40 425
Keiko Kinuya Japan 13 168 1.3× 67 0.6× 92 0.9× 95 1.2× 43 0.5× 32 387
Michelle Roytman United States 13 114 0.9× 83 0.8× 116 1.2× 68 0.8× 44 0.6× 41 545

Countries citing papers authored by Erkan İbiş

Since Specialization
Citations

This map shows the geographic impact of Erkan İbiş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkan İbiş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkan İbiş more than expected).

Fields of papers citing papers by Erkan İbiş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkan İbiş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkan İbiş. The network helps show where Erkan İbiş may publish in the future.

Co-authorship network of co-authors of Erkan İbiş

This figure shows the co-authorship network connecting the top 25 collaborators of Erkan İbiş. A scholar is included among the top collaborators of Erkan İbiş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkan İbiş. Erkan İbiş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araz, Mine, Çiğdem Soydal, Elgin Özkan, et al.. (2018). The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nuclear Medicine Communications. 39(11). 989–994. 34 indexed citations
2.
Soydal, Çiğdem, et al.. (2015). Radioembolization with 90Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors. Annals of Nuclear Medicine. 30(1). 29–34. 26 indexed citations
3.
Kır, Metin, et al.. (2015). The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer. Molecular Imaging and Radionuclide Therapy. 24(1). 15–20. 24 indexed citations
4.
İçlı, Fikri, et al.. (2013). Fighting Against Cigarette Smoking Among Medical Students: A Success Story. Journal of Cancer Education. 29(3). 458–462. 5 indexed citations
5.
Özkan, Elgin, Çiğdem Soydal, Mine Araz, Gülseren Araş, & Erkan İbiş. (2012). The Additive Clinical Value of 18F-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels. Clinical Nuclear Medicine. 37(8). 755–758. 31 indexed citations
6.
Özkan, Elgin, Çiğdem Soydal, Mine Araz, Metin Kır, & Erkan İbiş. (2012). The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. Nuclear Medicine Communications. 33(4). 395–402. 31 indexed citations
7.
Özkan, Elgin, et al.. (2011). Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma. Nuclear Medicine Communications. 32(12). 1162–1168. 9 indexed citations
8.
Küçük, Ömer, et al.. (2006). Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: Comparison with 99mTc-MIBI scans. Nuclear Medicine Communications. 27(11). 873–876. 12 indexed citations
9.
Küçük, Ömer, et al.. (2006). Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Nuclear Medicine Communications. 27(4). 377–379. 7 indexed citations
10.
Öner, Özgür, et al.. (2004). Regional cerebral blood flow in children with ADHD: changes with age. Brain and Development. 27(4). 279–285. 13 indexed citations
12.
Araş, Gülseren, et al.. (2002). Utility of Tc-99m Human Polyclonal Immunoglobulin G Scintigraphy for Assessing the Efficacy of Yttrium-90 Silicate Therapy in Rheumatoid Knee Synovitis. Clinical Nuclear Medicine. 27(6). 395–400. 5 indexed citations
13.
Karnak, Demet, et al.. (2001). Evaluation of Cyfra 21-1: A Potential Tumor Marker for Non-Small Cell Lung Carcinomas. Lung. 179(1). 57–65. 12 indexed citations
14.
Deda, Gülhıs, et al.. (2001). Cerebral blood flow abnormalities in symptomatic West syndrome: A single photon emission computed tomography study. Pediatrics International. 43(1). 66–70. 2 indexed citations
15.
Küçük, Ömer, et al.. (2000). In-111 platelets used in evaluation of emboli and thrombi in patients with cerebrovascular accident. Annals of Nuclear Medicine. 14(4). 319–322. 1 indexed citations
16.
Küçük, Ömer, et al.. (2000). Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Annals of Nuclear Medicine. 14(4). 239–45. 18 indexed citations
17.
Küçük, Ömer, et al.. (2000). False-Positive Results Obtained with Stress Myocardial SPECT in Patients with Right Bundle Branch Block. Clinical Nuclear Medicine. 25(8). 585–587. 4 indexed citations
18.
İbiş, Erkan, et al.. (1995). Extraosseous uptake of 99mTechnetium phosphate in an extremity. Seminars in Nuclear Medicine. 25(4). 352–354. 3 indexed citations
19.
İbiş, Erkan, et al.. (1992). Liver uptake of technetium-99m-labeled phosphate compounds; an update Gamut, 1992. Seminars in Nuclear Medicine. 22(3). 202–205. 4 indexed citations
20.
İbiş, Erkan, et al.. (1991). Postoperative goitre recurrence rate in Turkey. European Journal of Endocrinology. 125(1). 33–37. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026